Story perspectives

Psilocybin Shows Promise in Combating Obesity and Diabetes

2/16/2026

Summary

Story summary

A study in Pharmacological Research found low-dose psilocybin reduced weight gain and insulin resistance in mice.
It also reduced fatty liver symptoms and hyperglycemia without affecting the central nervous system.
Researchers led by Martina Colognesi aimed to test psilocybin as a non-psychedelic therapy for obesity, diabetes, and liver steatosis.
The study showed metabolic improvements and greater muscle strength, suggesting a potential therapeutic strategy despite the mouse model.

1 of 1

Story summary

A study in Pharmacological Research found low-dose psilocybin reduced weight gain and insulin resistance in mice.
It also reduced fatty liver symptoms and hyperglycemia without affecting the central nervous system.
Researchers led by Martina Colognesi aimed to test psilocybin as a non-psychedelic therapy for obesity, diabetes, and liver steatosis.
The study showed metabolic improvements and greater muscle strength, suggesting a potential therapeutic strategy despite the mouse model.